Page 6 - Vivos Method News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Westaim (OTCMKTS:WEDXF – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Valuation and Earnings This table compares Vivos Therapeutics and Westaim’s […]

Westaim (OTCMKTS:WEDXF – Get Rating) and Vivos Therapeutics (NASDAQ:VVOS – Get Rating) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Profitability This table compares Westaim and Vivos Therapeutics’ net […]

Vivos, a maker of oral appliances for treating breathing-related sleep disorders, implemented initiatives to improve operational efficiencies.

LITTLETON, Colo., May 01, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic

Vivos Therapeutics (NASDAQ:VVOS), Inc has announced its fiscal 2022 financial results and provided an operational update, saying it believes its 2022 and...